This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated bullish coverage on VRT, VYLR, ATHR, LMRI and NVT, assigning Buy or Outperform ratings and price targets.
Stocks · News reference
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18
Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18
Keybanc analyst Matthew Gillmor initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $18.